The DCRI’s Sheng Luo on the benefit of biostatistics
DCRI biostatisticians play a key role in many of the organization’s projects.
DCRI-led think tank addresses opportunities and challenges of digital technology in health care
The DCRI brought together national leaders to address the promise and challenges facing digital health technologies in the transformation of health care.
DCRI, University of Oxford to collaborate on chronic kidney disease study
EMPA-KIDNEY will study the effects of empagliflozin in CKD patients with and without diabetes.
Heart patients help doctors determine best aspirin dose
The ADAPTABLE study, coordinated by the DCRI, will enroll as many as 15,000 cardiac patients to determine the optimal aspirin dose.
DCRI to coordinate national study of childhood health
The DCRI will serve as the coordinating center for ECHO, which will examine how environmental factors affect childhood health.
Boehringer Ingelheim and DCRI expand collaboration to create largest patient registry for IPF
Boehringer Ingelheim Pharmaceuticals, Inc. and the DCRI announced today the expansion of the Idiopathic Pulmonary Fibrosis – PROspective Outcomes (IPF-PRO) Registry, a patient registry developed to uncover insights into IPF, a rare and serious lung disease. The expansion will increase the study enrollment from 300 patients at 18 study sites to 1,500 patients at approximately 45 sites, creating the largest registry of newly diagnosed IPF patients.
New NIH-funded center to study inefficiencies in clinical trials
The center will be a key component of the Trial Innovation Network, which is the newest part of the Clinical and Translational Science Award Program.
DIA 2016: DCRI researchers discuss how ADAPTABLE could change clinical trials
The DCRI’s Adrian Hernandez, MD, MHS, and Lesley Curtis, PhD, examined the challenges and opportunities of running one of the largest pragmatic clinical trials.